DEVELOPMENT OF DOXORUBICIN – ADSORBED MAGNETIC NANOPARTICLES MODIFIED WITH BIOCOMPATIBLE COPOLYMERS FOR TARGETED DRUG DELIVERY IN LUNG CANCER